Novel poly(ethylene glycol) modified compounds and uses thereof

Details for Australian Patent Application No. 2004238869 (hide)

Owner Affymax, Inc.

Inventors Holmes, Christopher P.; Tumelty, David; Yin, Qun

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004238869

PCT Pub. Number WO2004/101600

Priority 60/470,246 12.05.03 US

Filing date 12 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 25 June 2009

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 1/107 (2006.01) General processes for the preparation of peptides

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/101600 Priority application(s): WO2004/101600

25 June 2009 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Holmes, Chris to Holmes, Christopher P.; from Yin, Kevin to Yin, Qun and delete the co-inventors name Balu, Palani; Schatz, Peter and Lalonde, Guy

25 June 2009 Application Accepted

  Published as AU-B-2004238869

22 October 2009 Standard Patent Sealed

10 December 2009 Licence Registered

  Affymax, Inc. ( Takeda Pharmaceutical Company Limited ) Mortgages Registered - Section 187, Reg. 19 (The name in the parentheses is that of the mortgagee)

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238870-Novel peptides that bind to the erythropoietin receptor

2004238868-Peptides that bind to the erythropoietin receptor